HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markus W Büchler Selected Research

Pancreaticoduodenectomy

11/2022Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy.
1/2022Celiac Axis Stenosis is an Underestimated Risk Factor for Increased Morbidity after Pancreatoduodenectomy.
1/2022Protocol of a prospective study investigating the association of PAncreatic parenchymal RISk factors with postoperative pancreatic fistula after partial pancreaticoduodenectomy (PARIS trial).
1/2022Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve.
11/2021Splenorenal shunt for reconstruction of the gastric and splenic venous drainage during pancreatoduodenectomy with resection of the portal venous confluence.
9/2021[Ampullary neoplasms: surgical management].
1/2021Hyperamylasemia and acute pancreatitis after pancreatoduodenectomy: Two different entities.
1/2020Symptomatic marginal ulcer after pancreatoduodenectomy.
1/2020Escherichia coli Bacterobilia Is Associated with Severe Postoperative Pancreatic Fistula After Pancreaticoduodenectomy.
1/2020Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Markus W Büchler Research Topics

Disease

192Neoplasms (Cancer)
04/2022 - 01/2002
180Pancreatic Neoplasms (Pancreatic Cancer)
12/2022 - 01/2002
61Adenocarcinoma
11/2022 - 04/2002
44Chronic Pancreatitis
09/2017 - 04/2001
39Pancreatitis
04/2022 - 01/2002
39Neoplasm Metastasis (Metastasis)
01/2021 - 01/2002
29Pancreatic Fistula (Pancreatic Fistulas)
11/2022 - 01/2002
21Rectal Neoplasms (Rectal Cancer)
01/2021 - 01/2005
20Pain (Aches)
01/2020 - 04/2001
16Hemorrhage
07/2022 - 06/2002
14Inflammation (Inflammations)
01/2020 - 04/2001
14Reperfusion Injury
01/2018 - 07/2004
13Margins of Excision
01/2021 - 01/2008
13Infections
11/2019 - 01/2002
12Hepatocellular Carcinoma (Hepatoma)
11/2020 - 03/2004
12Wounds and Injuries (Trauma)
01/2020 - 04/2002
12Necrosis
01/2018 - 01/2002
11Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 09/2002
10Ischemia
01/2022 - 04/2005
10Carcinoma (Carcinomatosis)
01/2022 - 04/2002
10Anastomotic Leak
11/2021 - 05/2002
9Acute Cholecystitis
08/2015 - 01/2007
8Postoperative Pain
01/2021 - 11/2006
8Sepsis (Septicemia)
01/2021 - 06/2002
8Cholangitis
04/2020 - 01/2007
8Fibrosis (Cirrhosis)
11/2013 - 04/2002
7Fistula
07/2022 - 08/2006
7Hypoxia (Hypoxemia)
02/2012 - 01/2003
6Acute Necrotizing Pancreatitis
07/2022 - 01/2002
6Incisional Hernia
10/2021 - 03/2005
6Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 04/2002
6Diabetes Mellitus
01/2020 - 10/2006
6Wound Infection (Wound Infections)
12/2018 - 07/2004
6End Stage Liver Disease
01/2014 - 09/2005
5Surgical Wound Infection
06/2022 - 11/2011
5Liver Failure
01/2022 - 09/2002
5Cysts
01/2019 - 01/2004
5Obesity
01/2018 - 10/2006
5Type 2 Diabetes Mellitus (MODY)
09/2017 - 06/2013
5Thrombosis (Thrombus)
05/2017 - 01/2005
5Disease Progression
01/2016 - 08/2005

Drug/Important Bio-Agent (IBA)

60Messenger RNA (mRNA)IBA
11/2021 - 04/2001
42Proteins (Proteins, Gene)FDA Link
11/2020 - 08/2002
17GemcitabineFDA Link
11/2021 - 01/2002
14EnzymesIBA
01/2022 - 01/2002
14Pharmaceutical PreparationsIBA
01/2020 - 01/2002
14Anti-Bacterial Agents (Antibiotics)IBA
12/2018 - 01/2002
13AntigensIBA
12/2022 - 04/2005
13Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2009
12LigandsIBA
02/2020 - 01/2002
11Fluorouracil (Carac)FDA LinkGeneric
11/2021 - 01/2002
9Insulin (Novolin)FDA Link
09/2017 - 03/2003
9CytokinesIBA
09/2017 - 01/2003
9Transforming Growth Factor beta (TGF-beta)IBA
05/2007 - 01/2002
8CeruletideIBA
03/2012 - 03/2004
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011 - 12/2002
8AntibodiesIBA
04/2010 - 10/2002
8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2006 - 09/2002
7Biological ProductsIBA
12/2015 - 11/2003
6C-Reactive ProteinIBA
12/2022 - 01/2007
6RNA (Ribonucleic Acid)IBA
01/2021 - 04/2002
6Oxygen (Dioxygen)IBA
01/2021 - 01/2003
6Phosphotransferases (Kinase)IBA
11/2011 - 11/2003
6GlucocorticoidsIBA
01/2009 - 03/2006
5AlbuminsIBA
12/2022 - 03/2004
5AmylasesFDA Link
01/2021 - 09/2007
5Leucovorin (Folinic Acid)FDA Link
03/2019 - 09/2010
5Tyrosine Kinase InhibitorsIBA
03/2016 - 11/2002
5Epithelial Cell Adhesion MoleculeIBA
06/2015 - 09/2009
5DNA (Deoxyribonucleic Acid)IBA
02/2015 - 01/2003
5Neoplasm Antigens (Tumor Antigens)IBA
02/2015 - 11/2005

Therapy/Procedure

88Therapeutics
01/2022 - 06/2002
46Drug Therapy (Chemotherapy)
06/2022 - 01/2002
40Pancreatectomy
12/2022 - 12/2003
38Pancreaticoduodenectomy
11/2022 - 04/2002
35Neoadjuvant Therapy
04/2022 - 08/2008
25Length of Stay
11/2022 - 11/2005
21Liver Transplantation
10/2019 - 07/2004
17Adjuvant Chemotherapy
01/2022 - 03/2004
16Radiotherapy
02/2020 - 05/2002
14Transplantation
01/2022 - 07/2004
14Chemoradiotherapy
01/2021 - 03/2004
13Operative Surgical Procedures
12/2020 - 06/2002
12Laparotomy
10/2021 - 01/2004
11Cholecystectomy
08/2015 - 01/2002
10Lymph Node Excision (Lymph Node Dissection)
09/2021 - 01/2004
9Lasers (Laser)
01/2021 - 06/2002
9Sutures (Suture)
10/2014 - 01/2002
7Hepatectomy
12/2020 - 03/2009
6Esophagectomy
01/2021 - 08/2006
6Gastric Bypass (Roux-en-Y Gastric Bypass)
09/2017 - 01/2012
6Proctectomy
01/2017 - 03/2007
6Immunotherapy
02/2015 - 08/2005
6Critical Care (Surgical Intensive Care)
08/2011 - 01/2002
5Stents
11/2021 - 03/2005
5Ligation
11/2021 - 09/2007
5Gastrectomy
10/2021 - 12/2004
5Operative Time
01/2021 - 03/2006
5Ileostomy
10/2020 - 02/2011
5Kidney Transplantation
01/2020 - 07/2004